FFA
NVCR icon

Farther Finance Advisors’s NovoCure NVCR Stock Holding History

Farther Finance Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$33.2K Buy
2,083
+411
+25% +$6.86K ﹤0.01% 3757
2026
Q2 		$25.4K Buy
1,672
+558
+50% +$8.44K ﹤0.01% 3794
2026
Q1 		$12.1K Buy
1,114
+370
+50% +$4.62K ﹤0.01% 3981
2025
Q4 		$9.62K Sell
744
-306
-29% -$3.93K ﹤0.01% 3947
2025
Q3 		$13.6K Buy
1,050
+556
+113% +$7.43K ﹤0.01% 3277
2025
Q2 		$8.79K Sell
494
-203
-29% -$3.54K ﹤0.01% 3138
2025
Q1 		$12.2K Buy
697
+443
+174% +$10.1K ﹤0.01% 2644
2024
Q4 		$7.57K Buy
254
+108
+74% +$2.29K ﹤0.01% 2487
2024
Q3 		$2.28K Buy
146
+17
+13% +$308 ﹤0.01% 2954
2024
Q2 		$2.24K Buy
129
+37
+40% +$651 ﹤0.01% 2751
2024
Q1 		$1.43K Sell
92
-264
-74% -$3.88K ﹤0.01% 2637
2023
Q4 		$5.32K Buy
356
+339
+1,994% +$4.54K ﹤0.01% 1942
2023
Q3 		$275 Buy
17
+13
+325% +$375 ﹤0.01% 2408
2023
Q2 		$166 Buy
+4
New +$248 ﹤0.01% 2385

Other funds holding NVCR

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return

Farther Finance Advisors's NVCR Position: Q3 2026 in Review

Farther Finance Advisors increased its NovoCure (NVCR) stake by 25% in Q3 2026, buying an estimated $6.86K and bringing the position to 2,083 shares worth $33.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3757.

Farther Finance Advisors first reported a position in NVCR in Q2 2023 and has held it in 14 quarters since. 15 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.

  • Farther Finance Advisors held 2,083 shares of NovoCure worth $33.2K as of Q3 2026.
  • Farther Finance Advisors bought 411 NovoCure shares in Q3 2026, an estimated $6.86K.
  • NovoCure made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3757 holding.
  • Farther Finance Advisors first reported a position in NovoCure in Q2 2023 and has held it in 14 quarters since.
  • 15 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.